Lobbying activity

Q1

PFIZER INC. for PFIZER INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for SURGENEX

1st Quarter (Jan 1 - Mar 31) 2026 · Arizona · House · Senate · $50,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for STOKE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for RARE DISEASE COMPANY COALITION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for PALANTIR TECHNOLOGIES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income

Defense, Health Issues, Homeland Security, Science/Technology

View → Q1

ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate

Health Issues, Medicare/Medicaid

View → Q1

FEROX STRATEGIES for NATIONAL RETAIL FEDERATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Financial Institutions/Investments/Securities, Taxation/Internal Revenue Code, Law Enforcement/Crime/Criminal Justice, Consumer Issues/Safety/Products

View → Q1

POINTCLICKCARE TECHNOLOGIES USA CORP. for POINTCLICKCARE TECHNOLOGIES USA CORP.

1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate

Health Issues

View → Q1

FEROX STRATEGIES for NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA)

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $50,000.00 income

Health Issues, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for FRESENIUS KABI USA LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $50,000.00 income

Health Issues, Pharmacy, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for DIAGEO NORTH AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Taxation/Internal Revenue Code, Health Issues

View → Q1

FEROX STRATEGIES for COVISTA (FORMERLY KNOWN AS ADTALEM GLOBAL EDUCATION)

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income

Education, Budget/Appropriations, Health Issues, Taxation/Internal Revenue Code

View → Q1

FEROX STRATEGIES for AVIDITY BIOSCIENCES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $80,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for ATRIUM THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income

Health Issues

View → Q1

FORBES-TATE for ALEXION PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP for CHSPSC, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Tennessee · House · Senate · $90,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for AGE IN PLACE

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $30,000.00 income

Health Issues

View → Q1

FEROX STRATEGIES for ASSOCIATION FOR ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income

Copyright/Patent/Trademark, Health Issues, Pharmacy

View → Q1

TWENTY-FIRST CENTURY GROUP, INC. for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX)

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $24,000.00 income

Health Issues, Medical/Disease Research/Clinical Labs, Veterans, Budget/Appropriations

View → Q1

CAREQUEST INSTITUTE FOR ORAL HEALTH, INC. for CAREQUEST INSTITUTE FOR ORAL HEALTH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate

Medicare/Medicaid, Health Issues

View → Q1

TWENTY-FIRST CENTURY GROUP, INC. for CARDINAL HEALTH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate · $24,000.00 income

Health Issues, Pharmacy, Disaster Planning/Emergencies, Budget/Appropriations

View → Q1

TIBER CREEK GROUP for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Budget/Appropriations

View → Q1

NOVEL STRATEGIES (FKA) PRISM GROUP for INCUBATE

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Health Issues

View →